Fusion of hC3d3 to hCGβ enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge

Journal of Reproductive Immunology

Volumn 78, Issue 2, 2008, Pages 115-124

  Li, Hua Ping ^a,c   He, Xiao Ju ^a,d   Tang, Chuan ling ^a   Yao, Xiao Ying ^a   Li, Da Jin ^a,b  

^a FUDAN UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^d Shanghai Changning Maternity and Infant Health Institute   (China)

Author keywords

CD154 CD25; CD80 CD86; hCG ; Human molecular adjuvant hC3d; IL 2

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CHORIONIC GONADOTROPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA C3D3 FUSION PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; REAGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT; COMPLEMENT COMPONENT C3D; CONTRACEPTIVE VACCINE; IL2 PROTEIN, HUMAN;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; CRICETULUS; GENETIC TRANSFECTION; HAMSTER; IMMUNOLOGY; LYMPHOCYTE FUNCTION; METABOLISM;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CD40 LIGAND; CHO CELLS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COMPLEMENT C3D; CRICETINAE; CRICETULUS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COOPERATION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION; VACCINES, CONTRACEPTIVE;

EID: 46549086393     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2008.03.004     Document Type: Article

References (28)

1. Banki Z., Kacani L., Rusert P., Pruenster M., Wilflingseder D., Falkensammer B., Stellbrink H.J., van Lunzen J., Trkola A., Dierich M.P., and Stoiber H. Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS 19 (2005) 481-486
2. Breukels M.A., Zandvoort A., Rijkers G.T., Lodewijk M.E., Klok P.A., Harms G., and Timens W. Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines. Scand. J. Immunol. 61 (2005) 322-328
3. Carroll M.C. The role of complement in B cell activation and tolerance. Adv. Immunol. 74 (2000) 61-88
4. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 (1992) 105-107
5. Carter R.H., Spycher M.O., Ng Y.C., Hoffman R., and Fearon D.T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141 (1988) 457-463
6. Cekan S.Z., and Aedo A.R. Assays of antibodies to a C-terminal peptide or the entire β-subunit of human chorionic gonadotropin. J. Clin. Lab. Anal. 12 (1998) 60-64
7. Cherukuri A., Cheng P.C., Sohn H.W., and Pierce S.K. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14 (2001) 169-179
8. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 (1996) 348-350
9. Fakher M., Wu J., Qin D., Szakal A., and Tew J. Follicular dendritic cell accessory activity crosses MHC and species barriers. Eur. J. Immunol. 31 (2001) 176-185
10. Fingeroth J.D., Benedict M.A., Levy D.N., and Strominger J.L. Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 242-246
11. Fischer M.B., Goerg S., Shen L., Prodeus A.P., Goodnow C.C., Kelsoe G., and Carroll M.C. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280 (1998) 582-585
12. Green T.D., Newton B.R., Rota P.A., Xu Y., Robinson H.L., and Ross T.M. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 20 (2002) 242-248
13. Green T.D., Montefiori D.C., and Ross T.M. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J. Virol. 77 (2003) 2046-2055
14. Haas K.M., Toapanta F.R., Oliver J.A., Poe J.C., Weis J.H., Karp D.R., Bower J.F., Ross T.M., and Tedder T.F. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 172 (2004) 5833-5837
15. Kozono Y., Abe R., Kozono H., Kelly R.G., Azuma T., and Holers V.M. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160 (1998) 1565-1672
16. Li D.J., Wang H.M., Li L., Zhao X.R., Wang M.Y., Zhu Y., Meng Y., and Yuan M.M. Gene fusion of molecular adjuvant C3d to hCGβ enhances the anti-hCGβ antibody response in DNA immunization. J. Reprod. Immunol. 60 (2003) 129-141
17. Lyubchenko T., Porto D.J., Cambier J.C., and Holers V.M. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway. J. Immunol. 174 (2005) 3264-3272
18. O'Rand M.G., and Lea I.A. Designing an effective immunocontraceptive. J. Reprod. Immunol. 36 (1997) 51-59
19. Pierce S.K. Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2 (2002) 96-105
20. Rose N.R. Immunological hazards associated with vaccination of humans. J. Autoimmun. 14 (2000) 11-13
21. Ross T.M., Xu Y., Bright R.A., and Robinson H.L. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1 (2000) 127-131
22. Stevens V.C. Antifertility vaccines. In: Perlmann P., and Wigzell H. (Eds). Handbook of Experimental Pharmacology (1999), Springer-Verlag 443-461
23. Talwar G.P., Singh O.M., Pal R., Chatterjee N., SahaI P., Dhall K., Kaur J., Das S.K., Suri S., Budkshee K., Saraya L., and Saxena B.N. A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8532-8536
24. Talwar G.P. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol. Rev. 171 (1999) 173-192
25. Terrazzini N., Hannesdottir S., Delves P.J., and Lund T. DNA immunization with plasmids expressing hCGbeta-chimeras. Vaccine 22 (2004) 2146-2153
26. Wang X.L., Li D.J., Yuan M.M., Yu M., and Yao X.Y. Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3. J. Reprod. Immunol. 63 (2004) 97-110
27. 3 to hCGβ increased the anti-hCGβ Th2 and humoral immune response in DNA immunization. J. Gene Med. 8 (2006) 498-505
28. Yu Min., Li D.J., Wang X.L., Zhao X.R., and Yao X.Y. Molecular adjuvant C3d up-regulates both B7-1 and B7-2 expression on Raji cells. J. Mol. Cell. Biol. 39 (2006) 77-82